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A B S T R A C T
Recurrent spreading depolarizations occur in the cerebral cortex from minutes up to weeks following acute brain
injury. Clinical evidence suggests that the immediate reduction of cerebral blood ﬂow in response to spreading
depolarization importantly contributes to lesion progression as the wave propagates over vulnerable tissue
zones, characterized by potassium concentration already elevated prior to the passage of spreading depolar-
ization. Here we demonstrate with two-photon microscopy in anesthetized mice that initial vasoconstriction in
response to SD triggered experimentally with 1M KCl is coincident in space and time with the large extracellular
accumulation of potassium, as shown with a potassium indicator ﬂuorescent dye. Moreover, pharmacological
manipulations in combination with the use of potassium-sensitive microelectrodes suggest that large-con-
ductance Ca2+-activated potassium (BK) channels and L-type voltage-gated calcium channels play signiﬁcant
roles in the marked initial vasoconstriction under elevated baseline potassium. We propose that potassium eﬄux
through BK channels is a central component in the devastating neurovascular eﬀects of spreading depolariza-
tions in tissue at risk.
1. Introduction
Spreading depolarization (SD) is the generic term for all waves of
abrupt, near-complete breakdown of the neuronal transmembrane ion
gradients that cause cytotoxic edema and propagate at about 3mm/min
in cerebral gray matter. The SD continuum describes the spectrum from
short-lasting SDs in metabolically intact tissue to SDs of intermediate
duration to terminal SD in severely ischemic tissue (Dreier and
Reiﬀurth, 2015; Hartings et al., 2017). Accordingly, SDs occur in neu-
rological disorders such as the apparently harmless migraine aura, an-
eurysmal subarachnoid hemorrhage, traumatic brain injury, malignant
hemispheric stroke, or circulatory arrest (Dreier et al., 2009; Farkas
et al., 2010; Lauritzen et al., 2011; Hinzman et al., 2014; Woitzik et al.,
2013; Dreier et al., 2018).
SD is associated with a cerebral blood ﬂow (CBF) response con-
sisting of distinct phases (Ayata and Lauritzen, 2015). The main
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hyperemic element of the CBF response is preceded by a short-lasting
hypoperfusion especially discernible in the mouse brain (Fig. 1A). This
early hypoperfusion has been identiﬁed as the most important para-
meter in the spectrum from normal hyperemic responses to inverse,
vasoconstrictive responses, because it appears to override ensuing hy-
peremia in the ischemic cortex, thereby jeopardizing the survival of
metabolically compromised tissue (Shin et al., 2006; Bere et al., 2014).
Because ruling vasoconstriction (i.e. spreading ischemia) hampers the
activation of energy-dependent membrane pumps such as the Na+/K+-
ATPase, hence, the recovery from SD (Major et al., 2017), it prolongs
the neuronal depolarization, the cytotoxic edema and the associated
toxic intraneuronal Ca2+ and Na+ surge. All these events together
augment the risk of irreversible injury. Despite major clinical relevance,
the mechanisms behind the CBF reduction in response to SD have not
been fully elucidated (Dreier, 2011).
Under physiological conditions, astrocytes mediate vasodilation via
Ca2+-dependent activation of large conductance K+ (BK) channels and
K+ release from astrocytic endfeet (Filosa et al., 2006). In turn, inward
rectiﬁer K+ channels of vascular smooth muscle cells (VSMC) open, the
VSMC membrane hyperpolarizes, and voltage-gated L-type Ca2+
channels (L-type VGCC) close, as long as the local rise in [K+]e remains
below 20mM. Potassium triggers constriction of cerebral vessels at a
concentration over 20mM (Kuschinsky et al., 1972; Golding et al.,
2000). SD is associated with a more than ten-fold elevation of [K+]e
from a baseline level of 3–4mM to 30–60mM (Vyskocil et al., 1972;
Somjen, 1979), thus reaching the vasoconstrictive concentration range.
From the beginning, K+ has been a prime suspect to be involved in the
initial constrictive element of the neurovascular response to SD (Dreier
et al., 1998; Windmüller et al., 2005).Transition from astrocyte-evoked
vasodilation to vasoconstriction occurs when the intra-astrocytic Ca2+
signal approximately doubles from normally 300–400 nM to
700–800 nM at the endfeet (Girouard et al., 2010). In this situation, BK
channel activation is strongly enhanced, because the probability of BK
channels to be open increases 16-fold when the cytoplasmic Ca2+
concentration doubles (Horrigan and Aldrich, 2002). As a consequence,
local [K+]e in the restricted perivascular space might exceed 20mM.
Under this condition, VSMCs depolarize, because the K+ equilibrium
potential declines, and L-type VGCCs open (Windmüller et al., 2005).
Inﬂux of Ca2+ then causes VSMCs to contract (Koide et al., 2012)
(Fig. 1). Our main goal was to prove the key role of K+ in the mediation
of SD-related vasoconstriction, and to explore the involvement of BK
channels and L-type VGCCs (Fig. 1).
It appears from previous investigations that the early vasoconstric-
tion following SD may also be augmented if [K+]e prior to or in be-
tween SD events is elevated over the physiological range (Dreier et al.,
2000). Indeed, in experimental models of focal cerebral ischemia or
subarachnoid hemorrhage, baseline [K+]e was found to increase from 3
to 6–9mM (Petzold et al., 2005; Hansen, 1977; Hansen and Zeuthen,
1981). In addition to predisposing the vessels to constrict in response to
SD, higher baseline [K+]e also predicted longer SD duration in brain
slices, unrelated to vascular tone (Dreier et al., 2001). These experi-
mental data have prompted us to analyze how the kinetics of K+ ac-
cumulation with SD may be related to baseline [K+]e prior to SD oc-
currence.
Changes in [K+]e have been traditionally acquired with K+-selec-
tive microelectrodes (Vyskocil et al., 1972; Hansen and Zeuthen, 1981),
which lack spatiotemporal resolution necessary to establish coupling
with CBF accurately. Recently, a novel K+-sensitive ﬂuorescent dye,
Fig. 1. Hypothesis driving the study, and pharmacological interventions utilized to prove the proposed concept. A, Spreading depolarization (SD; lowermost gray
line) causes K+ accumulation in the interstitium (Somjen, 2001; Pietrobon and Moskowitz, 2014); in turn, astrocytes take up surplus K+ (Larsen and MacAulay,
2017), and a parallel rise of intracellular Ca2+ concentration occurs (Attwell et al., 2010; Li et al., 2012) (white ① in Astrocyte). The increased concentration of Ca2+
opens large-conductance Ca2+-activated K+ (BK) channels at the endfeet to allow K+ eﬄux to the periarteriolar space (Girouard et al., 2010) (white ② in Astrocyte).
Potassium accumulating at high concentration at the perivascular space (> 20mM) drives the vascular smooth muscle cell (VSMC) membrane potential towards
depolarization (Koide et al., 2012) (black ① in SMC). In turn, VSMC voltage-sensitive Ca2+ channels (VGCC) open (balck ② in VSMC) to give way to Ca2+ inﬂux
(black ③ in VSMC), which induces vasoconstriction (Koide et al., 2012) (black ④ in VSMC). This molecular signaling cascade is believed to underlie the initial
hypoperfusion element of the cerebral blood ﬂow (CBF) response to SD. B, Paxilline, a blocker of BK channels, is thought to be selective at the astrocyte endfeet given
at concentrations below 1 μM (Girouard et al., 2010), and hinder the periarteriolar accumulation of K+, thereby promoting hyperpolarization. As a result, VGCCs stay
closed, and the vessel lumen is prone to be dilated. Paxilline administration, therefore, is expected to mitigate the early hypoperfusion element of the CBF response to
SD. C, Nimodipine, a selective L-type VGCC blocker is applied to target VSMC channels (Alborch et al., 1995), K+ current from astrocytes being presumably
unaltered. As a direct consequence, Ca2+ inﬂux is obstructed, vasoconstriction becomes hindered, and the initial hypoperfusion element of the CBF response to SD is
anticipated to be smaller in magnitude.
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Asante Potassium Green 2 (APG-2; TEFLabs, Inc., Austin, TX, USA) has
been applied successfully for the spatiotemporal monitoring of [K+]e
changes during ictal activity (Bazzigaluppi et al., 2015).
With the necessary tools now available, we set out to image SD-
related changes in [K+]e in association with rhodamine-dextran loaded
cortical blood vessels using two-photon microscopy in mice. In other
experiments, laser-Doppler ﬂowmetry in combination with the use of
K+-sensitive microelectrodes aided the quantitative evaluation of [K+]e
and CBF. In this set of experiments, we also aimed to contemplate on
the impact of baseline [K+]e gradually increasing into the pathophy-
siological range (i.e. over 2–4mM) on the kinetics of arising SD events.
Finally, pharmacological inhibition of BK channels or L-type VGCCs
revealed their contribution to the SD-induced initial vasoconstriction
under elevated baseline [K+]e (Fig. 1).
2. Materials and methods
The experimental procedures were approved by the National Food
Chain Safety and Animal Health Directorate of Csongrád County,
Hungary, conforming to the guidelines of the Scientiﬁc Committee of
Animal Experimentation of the Hungarian Academy of Sciences (up-
dated Law and Regulations on Animal Protection: 40/2013. (II. 14.)
Gov. of Hungary), following the EU Directive 2010/63/EU on the
protection of animals used for scientiﬁc purposes, and reported in
compliance with the ARRIVE guidelines.
Anesthetized, adult, male C57Bl/6 mice (n=23) were used for the
study. Standard rodent chow and tap water were supplied ad libitum.
The animals were housed under constant temperature, humidity, and
lighting conditions (23 °C, 12:12 h light/dark cycle, lights on at 7 a.m.).
There was no speciﬁc criterion formulated for inclusion or exclusion.
2.1. Two-photon microscopy
Mice (n=8) were anesthetized with 1% Avertin (20 μl/g, i.p.), and
mounted on a stereotactic frame incorporating a heating pad. A cranial
window (d= 3mm) was prepared on the right parietal bone, and the
dura was retracted. The exposed brain surface was loaded with APG-2
dissolved in Ringer-HEPES solution (150mM NaCl, 5.2mM KCl,
2.2 mM CaCl2, 0.2 mM MgCl2, 6 mM NaHCO3, 5mM HEPES, 2.8 mM D-
Glucose, pH=7.4) to a concentration of 0.76mM (n=7) (TEFLabs,
Inc., Austin, TX, USA) (Bazzigaluppi et al., 2015), or Ringer-HEPES
solution as negative control for APG-2 (n=1). The craniotomy was
then coverslipped with a microscopic cover glass. A second, smaller
trepanation was drilled rostral to the ﬁrst craniotomy, to be used for SD
elicitation (Fig. 2A). A glass capillary connected to a syringe pump
(CMA/100, CMA/Microdialysis, Solna, Sweden) was ﬁlled with 1M
KCl, and was fastened to the skull with acrylic dental cement, with its
tip positioned at the cortical surface within the rostral trepanation.
Blood vessels were then loaded with 2–10mg rhodamine-dextran
(D1841, Life Technologies Magyarország Kft. Budapest, Hungary) in
100 μl Ringer-HEPES by retro-orbital injection.
In vivo intracranial microscopy was performed with a FEMTO2D-
Alba microscope (Femtonics Ltd., Budapest, Hungary) using a 20×
large working distance water objective (XLUMPLFLN-20XW, Olympus)
using MES software (v4.6.2336, Femtonics). Two-photon excitation was
performed using a Mai Tai HP Ti-sapphire laser (RK TECH Ltd.,
Budapest, Hungary) at 810 nm, which was found optimal for APG-2
excitation, and also adequate for rhodamine. Emission was detected
with gallium arsenide phosphide photomultipliers, equipped with the
appropriate color ﬁlters. Laser power was set to 10–40% depending on
the depth of imaging (0–300 μm from the brain surface), photo-
multiplier voltages were set to 70%. A z-stack with 5 μm vertical steps
was recorded at the area of interest for identiﬁcation of arterioles and
venules, then image sequences were taken of the desired vessel cross
sections at approximately 1 μm/pixel spatial and 0.8–2Hz temporal
resolution.
After acquiring baseline images, SD was triggered repeatedly at
intervals of 15–20min in the rostral cranial window by the ejection of
1–4 μl 1 M KCl to the brain surface through the glass capillary. Image
sequences of APG-2 and rhodamine dextran were captured con-
tinuously for 10min. Image stacks were auto leveled, merged and
converted to RGB color in FIJI (Schindelin et al., 2012) for manual
vessel diameter measurements.
2.2. Electrophysiology and cerebral blood ﬂow assessment
Mice (n=15) were anesthetized with 1.5–2% isoﬂurane in N2O:O2
(2:1), and body temperature was maintained at 37 °C using a heating
pad (Harvard Apparatus, Holliston, MA, USA). Once the animal was
placed in a stereotactic frame, two adjacent craniotomies were opened
on the right parietal bone, with the dura left intact. The rostral window
was used for SD elicitation, while a K+-sensitive microelectrode and a
laser-Doppler ﬂowmetry probe were placed in the caudal window.
Ion-sensitive microelectrodes were prepared according to Viitanen
et al. (2010). Glass capillary microelectrode tips (outer diameter:
10–12 μm) were ﬁlled with a liquid K+-ion exchanger (Potassium io-
nophore I - cocktail A; Sigma) (Bazzigaluppi et al., 2015), and the shank
of the microelectrode was backﬁlled with 100mM KCl. Each K+-sen-
sitive microelectrode was calibrated in standard solutions of known K+
concentrations (1, 3, 5, 10, 30, 50, 100mM). In each experiment, a K+-
sensitive microelectrode was lowered into the cortex, together with
another microelectrode (tip diameter= 20 μm) ﬁlled with 150mM
NaCl and 1mM HEPES to serve as reference. The reference electrode
acquired local ﬁeld potential (LFP) ﬁltered in direct current (DC) po-
tential mode. An Ag/AgCl electrode implanted under the skin of the
animal's neck was used as common ground. Microelectrodes were
connected to a custom-made dual-channel high input impedance elec-
trometer (including AD549LH, Analog Devices, Norwood, MA, USA) via
Ag/AgCl leads. The voltage signal recorded by the reference electrode
was subtracted from that of the K+-sensitive microelectrode by dedi-
cated diﬀerential ampliﬁers and associated ﬁlter modules (NL106 and
NL125, NeuroLog System, Digitimer Ltd., United Kingdom), which
yielded potential variations related to changes in [K+]e. The recorded
signals were then forwarded to an analog-to-digital converter (MP 150,
Biopac Systems, Inc). Electric signals were continuously acquired at a
sampling frequency of 1 kHz. Changes of [K+]e were expressed in mV to
be translated into mM concentration oﬄine, using least squares linear
regression.
CBF variations were monitored with a laser-Doppler needle probe
(Probe 403 connected to PeriFlux 5000; Perimed AB, Sweden) posi-
tioned at an angle next to the penetration site of the K+-sensitive mi-
croelectrode. The ﬂow signal was digitized and displayed together with
the DC potential and K+ signals as described above (MP 150 and
AcqKnowledge 4.2.0, Biopac Systems, Inc. USA). The completed pre-
parations were enclosed in a Faraday cage.
2.3. Pharmacological treatments and elicitation of SD
Paxilline (a BK channel inhibitor), dissolved in artiﬁcial cere-
brospinal ﬂuid (aCSF; 500 nM; n=6; composition of aCSF in mM
concentrations: 126.6 NaCl, 3 KCl, 1.5 CaCl2, 1.2 MgCl, 24.5 NaHCO3,
6.7 urea, 3.7 glucose bubbled with 95% O2 and 5% CO2 to achieve a
constant pH of 7.4) or nimodipine (L-type VGCC blocker, dissolved in
0.1% DMSO, 100 μM; n=5) (Richter et al., 2002) were administered
topically in the caudal cranial window after the initiation of 2–3 SDs at
a 15min interval. Animal selection for treatment was random by al-
ternating treatment as the experimental work proceeded. Four sub-
sequent SDs, 15min apart, were elicited following 20min incubation in
drug solutions. Drug solutions were regularly refreshed (i.e. every
10min) until the termination of each experiment. The concentration of
paxilline was chosen with the guidance of a previous report (Girouard
et al., 2010) and reﬁned on the basis of our own pilot experiments
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utilizing 100, 500 nM and 1 μM concentration paxilline solutions (data
not shown). Control experiments (n=4) were carried out by rinsing
the caudal cranial window with aCSF throughout the experimental
protocol. In addition, recurrent SDs triggered before drug administra-
tion in the paxilline and nimodipine groups were also taken as control.
SDs were elicited in the rostral craniotomy by placing a cotton ball
soaked in 1M KCl on the cortical surface, and removing it after the
detection of each SD. In some cases (n=4), the cotton ball was left in
the cranial window, to achieve a gradual elevation of baseline K+
concentration at the site of data acquisition. This approach progres-
sively elevated K+ levels to reproduce conditions typical of injured
tissue, and enabled the assessment of the interaction between baseline
[K+]e, the kinetics of SD events, and the associated CBF response.
2.4. Application of paxilline to acute, live neocortical brain slices
Male, adult Sprague Dawley rats (body weight: 250 g; n=11) were
decapitated under deep anesthesia (4–5% isoﬂurane in N2O:O2; 2:1).
Brain slices were obtained following a previously established protocol
(Kocsis et al., 2016). Brieﬂy, coronal brain slices (350 μm) anterior to
bregma were cut with a vibrating blade microtome (Leica VT1000S),
and collected in ice-cold aCSF (composition of aCSF in mM con-
centrations: 130 NaCl, 3.5 KCl, 1 NaH2PO4, 24 NaHCO3, 1 CaCl2, 3
MgSO4 and 10 D-glucose). Six to eight slices were transferred to an
incubation chamber ﬁlled with carbogenated aCSF (diﬀerence in com-
position in mM concentrations: 3 CaCl2 and 1.5 MgSO4), and kept at
room temperature (~20 °C). Selected slices were placed into an inter-
face type recording tissue chamber (Brain Slice Chamber BSC1, Scien-
tiﬁc Systems Design Inc., Ontario, Canada) continuously perfused with
carbogenated aCSF at a rate of 2ml/min, and kept at 32 °C using a
dedicated proportional temperature controller unit (PTC03, Scientiﬁc
Systems Design Inc., Ontario, Canada).
For LFP recording, a glass capillary electrode (20 μm outside tip
diameter) ﬁlled with 150mM NaCl and 1mM HEPES was inserted into
layers 3–4 of the cerebral cortex, the bottom of the tissue chamber
containing an Ag/AgCl reference electrode. LFP was recorded via a
custom-made dual-channel high input impedance electrometer (in-
cluding AD549LH, Analog Devices, Norwood, MA, USA), connected to a
diﬀerential ampliﬁer (NL106, NeuroLog System, Digitimer Ltd., United
Kingdom) with associated ﬁlter and conditioner systems (NL125,
NL530, NeuroLog System, Digitimer Ltd., United Kingdom). Potential
line frequency noise (50 Hz) was removed by a high quality noise
eliminator (HumBug, Quest Scientiﬁc Instruments Inc., Canada)
without any signal attenuation. The resulting signal was digitalized by
an analog/digital (A/D) converter (MP150, Biopac Systems Inc., USA)
and continuously acquired at a sampling frequency of 1 kHz using the
software AcqKnowledge 4.2.0 (Biopac Systems Inc., USA).
SDs were triggered by electric stimulation as reported earlier
(Hertelendy et al., 2017). A concentric bipolar needle electrode (tip
size: 40 μm, Neuronelektród Kft., Hungary) was placed at a distance of
approximately 800–1000 μm from the recording electrode. The stimu-
lating electrode was connected to an opto-coupled stimulus isolator
with constant current output (NL 800, Digitimer Ltd., United Kingdom)
a pulse generator (NL301), a with-delay panel (NL405) and a pulse
buﬀer (NL510), which enabled the adjustment of the duration of the
stimuli at will. Stimulation was implemented with single, cathodal
constant current pulses. The charge delivered to achieve successful SD
elicitation ranged from 50 to 1500 μC. Four to six SDs were triggered in
each slice, at an interval of 12min. The stimulating electrode was re-
positioned prior to each SD, to optimize contact between the electrode
tip and viable tissue.
In control experiments (brain slices: n=4, SDs analyzed: n=20),
brain slices were kept in carbogenated aCSF throughout the experi-
mental protocol. For paxilline treatment, various concentrations of the
drug (dissolved in aCSF) were tested (100 nM: brain slices: n= 2 SDs
analyzed: n=10; 250 nM: brain slices: n= 2 SDs analyzed: n=12;
500 nM: brain slices: n=5 SDs analyzed: n=20) to select the lowest
eﬀective dose. The ﬁrst SD (SD1) in a train was triggered under aCSF to
serve as reference in each slice. Subsequent, recurrent SDs (rSD) were
elicited after paxilline administration.
2.5. Data processing and analysis
The optical signal of APG-2 was analyzed with a dedicated macro
written in the software ImagePro Plus (Media Cybernetics, Rockville,
MD, USA). Local changes in APG-2 ﬂuorescence intensity with time
were extracted by placing regions of interest (ROIs) of 15×15 μm size
(corresponding to the tip size of K+-sensitive microelectrodes) at se-
lected parenchymal locations in the image sequences.
Vascular lumen diameter changes were measured in the software
ImageJ (National Institute of Health, Bethesda, USA). Vascular changes
related to SD1 were analyzed apart from subsequent, rSD events. Pial
arterioles, penetrating arterioles and cortical venules were identiﬁed
with the help of 3D reconstruction relying on a z-stack of two-photon
Fig. 2. APG-2 ﬂuorescence intensity corresponds with variations in the extracellular concentration of potassium ([K+]e) during spreading depolarization (SD) over
the mouse parietal cortex. A, Schematic illustration shows the position of the cranial window (green) used for image acquisition, to aid the orientation of images in
Panels B1–7. SD events were triggered by KCl through a smaller craniotomy (open circle) frontal to the site of imaging and caudal to bregma (br). B1–7, Pseudo-
colored, contrast-enhanced, two-photon microscopic images demonstrate the progressive elevation of APG-2 ﬂuorescence intensity (green) with the propagation of
an SD (from fronto-medial to caudo-lateral direction). Optical APG-2 signal was intensiﬁed in the images by background subtraction over the green channel. The
vascular architecture is delineated by intravascular rhodamine dextran (red). Images were taken at a cortical depth of 50–55 μm. C, Measurement of [K+]e with ion-
sensitive glass microelectrodes (black trace, mean of 7 SD events) conﬁrms that the kinetics of APG-2 ﬂuorescence intensity extracted from a single region of interest
(green trace, mean of 6 SD events) indicates SD-related changes in [K+]e. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to
the web version of this article.)
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images of intravascular rhodamine dextran-loaded tissue (Fig. 3A–B).
3D images were constructed using the built-in 3D viewer in ImageJ 1.5i
with Java 1.6.0_24 (64 bit). Either cross sections (typically penetrating
arterioles or parenchymal venules) or longitudinal sections (pial ar-
terioles) in the focal plane of the recorded videos were selected for the
measurement of vascular lumen diameter changes. The criteria to in-
clude a vessel into the analysis were the following: the potassium wave
of SD must have propagated fully over the parenchyma next to the
vessel; The baseline diameter of penetrating arterioles was above 10 μM
in order to have reliable assessment of vasoconstriction with respect to
pixel size (i.e. 1 μm); the penetrating arteriole was a ﬁrst order arteriole
branching from a pial arteriole; the penetrating vessel optimally ap-
peared in cross sectional view. Three, independent investigators ran the
diameter analysis for each selected vessel, and the three data sets were
averaged.
Quantitative data are given as mean ± standard deviation (stdev).
Statistical analysis was conducted with the software SPSS (IBM SPSS
Statistics for Windows, Version 22.0, IBM Corp.). Data sets were eval-
uated by either a one-way analysis of variance (ANOVA) followed by a
Fisher post hoc test, or a Pearson one-tailed correlation analysis model.
Level of signiﬁcance was set at p < .05* or p < .01**. Appropriate
statistical methods are provided in each Figure legend in detail.
3. Results
3.1. Imaging the [K+]e wave of SD with two-photon microscopy
The ﬂuorescence intensity of APG-2 sharply increased with each SD
triggered (amplitude: 0.14 ± 0.03 ΔF/F, peak corresponding to [K+]e
of 35.5 ± 5.3mM measured in the electrophysiology series of experi-
ments) (Fig. 2). The increased ﬂuorescent signal propagated across the
ﬁeld of view at a rate of 3.36 ± 1.67mm/min, typical of SD. In the
absence of APG-2, but under otherwise identical experimental condi-
tions (control experiment), SD occurrence was conﬁrmed by typical
cerebrocortical vascular reactions, but no optical signal of SD was
captured. These observations validate that the optical signal acquired in
the APG-2 experiments was speciﬁc to the dye (Bazzigaluppi et al.,
2015). The APG-2 signature of SD lasted shorter than the [K+]e shift
recorded with ion-sensitive microelectrodes (29.8 ± 9.0 vs.
57.7.1 ± 17.8 s, respectively), but varied clearly within the same order
Fig. 3. A marked transient increase in the extracellular concentration of potassium ([K+]e) with the ﬁrst spreading depolarization in a train (SD1) is coincident with
vasoconstriction of penetrating arterioles at the SD wave-front, and a brief drop of local cerebral blood ﬂow (CBF), in the mouse parietal cortex. A, Schematic
illustration of the preparation in the upper left hand corner is provided for the orientation of images in Panels A-D. The cranial window used for image acquisition is
colored green. The full image presents a representative Z-projection of 130 images taken over a cortical depth of 200 μm. Blood vessels were loaded with rhodamine
dextran (red), and are delineated by traces of APG-2 (green/yellow). Arrows labeled with “a” designate arterioles, “v” labels venules. Note, that venules are devoid of
any APG-2 contour. The white frame outlines the area reconstructed in Panel B. B, Three-dimensional z-stack reconstruction of the microvascular architecture in the
cortical volume (depth= 200 μm) scanned by two-photon microscopy, which allows the identiﬁcation of vessel types. The arrow with “a” is pointing at a penetrating
arteriole and “v” indicates an adjacent venule, both shown in cross section in Panels C & D1–6. C, A pseudo-colored, contrast enhanced, representative, single snap
shot taken at a cortical depth of 50–55 μm is the ﬁrst image in a series used for the measurement of changes in vessel diameters. APG-2 loaded in the tissue is green;
red labels rhodamine dextran in vessels. The white frame indicates the area shown in Panels D1–6. D1–6, Series of images demonstrates constriction of a cortical
penetrating arteriole in response to SD1; the cross section of the tiny venule remains unaltered. E, Red trace and kymograph below depict SD1-associated diameter
changes of a penetrating arteriole, and blue trace stands for an irresponsive venule, both presented in Panels D1–6; Green trace shows the corresponding variation in
APG-2 ﬂuorescence indicative of [K+]e, derived from the same images. The kymograph was created in FIJI by correcting the image stack for drift using the Template
Matching plugin (Hsu et al., 2012) followed by the KymographBuilder plugin (DOI https://doi.org/10.5281/zenodo.591877) on a line drawn along the diameter of
the vessel. F, Representative traces demonstrate a typical [K+]e shift and the associated drop of CBF to SD1, recorded with an intracortical potassium-sensitive
microelectrode and laser-Doppler ﬂowmetry in a separate mouse. Note a good correspondence with the signals presented in Panel E. G, Absolute and relative changes
of penetrating arteriolar diameter, and duration of vasoconstriction in response to SD1, and recurrent SD (rSD) events. Data are given as mean ± stdev; n=12.
Sample size (i.e. number of vessels analyzed) is indicated in each bar. One-way analysis of variance (ANOVA) was used for statistical analysis; the level of signiﬁcance
is given as p* < 0.05 and p** < 0.01. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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of magnitude (Fig. 2C). In conclusion, features of the APG-2 ﬂuorescent
signal of SD convincingly suggest, that APG-2 indicates SD-related
changes in [K+]e (Fig. 2).
3.2. Vascular response to spreading depolarization in the mouse cortex
Vascular reaction to SD concerned arterioles only, which displayed
a robust constriction (Fig. 3A–E); venules did not undergo diameter
adjustment (Fig. 3E & 4C). Penetrating arterioles were taken for the
comparison of vascular reactions to SD1 and rSD events. SD1 induced
marked, transient arteriolar constriction alone (from 17.2 ± 3.4 to
7.1 ± 3.6 μm) (Fig. 3G). Subsequent rSDs caused an initial, short,
marked constriction of arterioles (from 16.4 ± 3.2 to 6.7 ± 5.1 μm),
followed by longer-lasting vasodilation (to 18.5 ± 3.2 μm, duration:
43.1 ± 18.3 s) (Fig. 3G). The degree of vasoconstriction was similar
but its duration was signiﬁcantly shorter-lasting for rSDs than for SD1
(15.7 ± 5.1 vs. 23.4 ± 3.5 s) (Fig. 3G). The observed changes in ar-
teriolar caliber were consistent with the kinetics of SD-related CBF
variations assessed with laser-Doppler ﬂowmetry in other mice (for
SD1: Fig. 3E–F, for rSDs: Fig. 4C–D). Overall, CBF transiently dropped
from 100.0 ± 0.8 to 74.0 ± 9.1% in response to SD1, and from
60.4 ± 5.1 to 47.4 ± 11.7% in response to rSDs. The subsequent
hyperemic element of the CBF response to rSDs peaked at 77.9 ± 8.1%
and persisted for 99.1 ± 61.7 s.
The baseline lumen diameter before rSDs was apparently narrower
for penetrating than for pial arterioles (16.4 ± 3.2 vs.
38.1 ± 10.2 μm), but their SD-related, maximal constriction relative to
baseline tone was essentially identical (34.0 ± 18.8 vs.
35.1 ± 10.3%) (Fig. 4E). Likewise, penetrating and pial arterioles later
dilated in response to rSD to an equal degree (113.0 ± 6.8 vs.
113.8 ± 5.8%), which persisted for a similar duration (43.1 ± 18.3
vs. 36.8 ± 2.9 s) (Fig. 4F). The duration of initial vasoconstriction
proved to be shorter for penetrating as compared with pial arterioles
(15.7 ± 5.1 vs. 26.8 ± 9.4 s) (Fig. 4F), consistent with the more rapid
progress of vasoconstriction in penetrating arterioles (i.e. maximal va-
soconstriction in pial arterioles was achieved with a delay of
3.31 ± 1.3 s with respect to penetrating arterioles).
3.3. Synchronicity of high [K+]e and constriction of cortical arterioles in
response to SD
Constriction of both pial and penetrating arterioles was in tight
Fig. 4. Both pial and penetrating arteriolar constriction are spatiotemporally synchronous with the elevation of the extracellular concentration of potassium ([K+]e)
with recurrent spreading depolarization (rSD). A, Schematic illustration of the preparation in the upper left hand corner is given for the orientation of images in
Panels B. The cranial window used for image acquisition is colored green. A pseudo-colored, contrast enhanced, representative, single snap shot taken at a cortical
depth of 50–55 μm shows the ﬁeld of view. APG-2 loaded in the tissue is green; red designates rhodamine dextran in vessels. The white frame outlines the area shown
in Panels B; white arrow labels a venule analyzed for Panel C. B, The positions of diameter measurement (d) of a pial arteriole in longitudinal view and a penetrating
arteriole in cross sectional view are aligned with a region of interest (ROI) used for the extraction of APG-2 ﬂuorescence intensity. All three measurement positions
are arranged along the front of an rSD wave to examine synchronicity between increasing APG-2 ﬂuorescence and arteriolar response. B1–7, Images illustrate diameter
changes of the selected pial and penetrating arterioles in response to rSD. Note the initial constriction in B1–3, and the subsequent dilation in B4–7. C, The green trace
representing APG-2 ﬂuorescence variation with rSD was acquired at the ROI shown in Panel B. Red traces illustrate the coupled arteriolar responses, while the blue
trace tracks diameter changes of the venule indicated by an arrow in Panel A. Black triangles above the traces give the sampling time of the images in Panels B1–7.
Note, that the peak intensity of APG-2 ﬂuorescence coincides with the onset of arteriolar constriction. D, A representative trace illustrates the local cerebral blood
ﬂow response to an rSD event, acquired with laser-Doppler ﬂowmetry over the parietal cortex of another mouse. Note a good correspondence to the reactions of
arterioles presented in Panel C. E, Absolute and relative changes of pial and penetrating arteriolar diameter in response to rSD. Data are given as mean ± stdev. F,
Duration of vasoconstriction and vasodilation in response to rSD. Data are given as mean ± stdev; n=11. Sample size (i.e. number of vessels analyzed) is indicated
in each bar. One-way analysis of variance (ANOVA) was used for statistical analysis; the level of signiﬁcance is given as p* < 0.05. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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spatiotemporal coupling with the SD-related peak of [K+]e. More spe-
ciﬁcally, the onset of vasoconstriction was essentially synchronous with
the peak APG-2 ﬂuorescence corresponding to the invading [K+]e wave
(Fig. 4A–C).
The electrophysiology series of experiments allowed the quantita-
tive assessment of the relationship between [K+]e and the early hypo-
perfusion element of the CBF response to SD. Although results obtained
from a number of experiments support the observations presented
below, a representative experiment shown in Fig. 5 has been selected to
demonstrate the strong link between these variables. This particular
experiment was found ideal because of the following favorable condi-
tions: (i) SD events could be studied in the face of baseline [K+]e
progressively increasing over the experiment from 2.86 to 18.08mM
(Fig. 5C), in the otherwise intact cortex (i.e. no vessel occlusion was
imposed). This [K+]e gradient departs from the physiological resting
state and reaches levels typical of the injured cortex (Hansen and
Zeuthen, 1981), but remains within the vasodilator range throughout.
This approach was expected to reveal the impact of increasing [K+]e on
the kinetics of subsequent SDs, independent of any initial limitation of
oxygen or glucose availability, and irrespective of any other complex
biochemical cascade of events that may take place during an ischemic
insult; (ii) The constant arrangement of the potassium-sensitive mi-
croelectrode and the laser Doppler probe allowed the monitoring of the
same cortical region by each modality from SD to SD, therefore, the
evaluation of any change in synchronicity between the [K+]e shift and
the CBF response to SD could be attained; (iii) A high enough number of
rSDs were successfully recorded and quantitated to serve statistical
analysis of correlation (n=8).
Correlation analysis conﬁrmed the anticipated lack of interaction
between increasing baseline [K+]e and resting CBF over the potassium
gradient examined (r=−0.171, p= .342). On the other hand, rising
baseline [K+]e predicted longer-lasting [K+]e shift with rSDs
(r=0.821, p= .006**) (Fig. 5D1), but had no signiﬁcant impact on the
absolute peak of [K+]e (r=0.580, p= .132) similar to previous ob-
servations in brain slices (Dreier et al., 2001). In turn, longer [K+]e shift
with rSDs was coincident with more prominent early hypoperfusion,
characterized by lower CBF minimum reached (r=−0.842,
p= .004**) (Fig. 5D2), and greater area under the curve (AUC)
(r=0.791, p= .010**) (Fig. 5D3) similar to previous observations in
rats (Dreier et al., 2000). In contrast, the magnitude of hypoperfusion
appeared unrelated to the absolute amplitude of the [K+]e shift (cor-
relation with CBF minimum: r=−0.147, p= .364; correlation with
AUC of hypoperfusion: r=0.282, p= .249).
3.4. Contribution of large-conductance Ca2+-activated K+ channels or L-
type voltage-gated Ca2+ channels to potassium-related vasoconstriction in
response to SD
The evaluation of pharmacological data focused on the early hy-
poperfusion element of the CBF response to SD. Only rSD events were
considered for the assessment of drug eﬀect, because each pharma-
cology experiment started with a control phase (i.e. SD1 was triggered
before drug application). In order to appreciate the anticipated in-
hibitory drug eﬀect on the magnitude of hypoperfusion, the control
condition was required to produce a sizeable drop of CBF. As shown
above, increasing baseline [K+]e prior to an SD event predicted greater
SD-associated hypoperfusion to follow (Fig. 5D1-3). Taking these points
into consideration, the analysis was conducted on rSDs, which were
preceded by a baseline [K+]e higher than 10mM. Following the same
reasoning, baseline [K+]e prior to rSDs was required to be similar
across experimental groups, for the comparison of pharmacological
treatments to be meaningful. Indeed, [K+]e varied within an over-
lapping range for all three conditions (16.5 ± 3.6 vs. 17.0 ± 3.2 vs.
14.9 ± 3.1mM, nimodipine vs. paxilline vs. control; one-way ANOVA:
Fig. 5. Association between extracellular potassium concentration ([K+]e) and the prominence of early hypoperfusion in response to recurrent spreading depo-
larization (SD) in the mouse cerebral cortex. A, Experimental preparation for conventional electrophysiological data acquisition. The caudal cranial window served as
recording site, and the rostral window was used for SD elicitation by the topical application of 1M KCl. B, Time line of a representative experiment indicates SD
events (vertical stripes) used for detailed analysis presented in Panels C and D1–3. C, Recurrent SD events (rSD; gray traces), the associated variation of [K+]e (black
traces) and the coupled cerebral blood ﬂow (CBF) response transformed as a function of increasing baseline [K+]e (initial segment of black traces). D, Correlation
analysis between baseline [K+]e and the duration of the transient rise of [K+]e with rSDs (D1), the duration of the transient rise of [K+]e and the minimum value of
the early hypoperfusion element of the CBF response to rSD (D2), and the duration of the transient rise of [K+]e and the area under the curve (AUC) of early
hypoperfusion (D3). A Pearson one-tailed model was used for statistical analysis (n=8), with the level of signiﬁcance set at p* < 0.05 and p** < 0.01.
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f = 1.175, p < .322; Fig. 6E).
Both paxilline and nimodipine treatment exerted a substantial im-
pact on the CBF response to rSDs under these carefully selected con-
ditions, by impeding the element of initial hypoperfusion and aug-
menting subsequent peak hyperemia of the CBF response (Fig. 6A).
Paxilline, in particular, completely diminished rSD-related hypoperfu-
sion in 6 of 7 cases (Fig. 6B). Nimodipine proved to be less potent;
nevertheless, it reduced the magnitude of hypoperfusion (i.e. area
under the curve) to the half of the control value (Fig. 6C). Further,
paxilline and nimodipine reduced the amplitude of the DC shift with
rSDs equally (11.8 ± 6.2 vs. 11.00 ± 5.3 vs. 19.3 ± 4.5mV, nimo-
dipine vs. paxilline vs. control; Fig. 6D). Finally, both drugs hampered
the extracellular accumulation of K+ with rSDs, which was reﬂected by
the smaller relative amplitude (16.4 ± 6.5 vs. 12.7 ± 7.5 vs.
22.2 ± 2.7mM, nimodipine vs. paxilline vs. control) and absolute
amplitude (32.9 ± 4.4 vs. 29.7 ± 5.4 vs. 37.0 ± 3.5mM, nimodipine
vs. paxilline vs. control; Fig. 6E), and slower rate of rSD-related K+
surge (i.e. slope; 0.89 ± 0.72 vs. 0.54 ± 0.27 vs. 2.57 ± 0.89mM/s,
nimodipine vs. paxilline vs. control; Fig. 6F). The reduction of the DC
amplitude by the treatments appeared to be coincident with the smaller
K+ shift of SD, as indicated by the strong positive correlation between
the two variables (Fig. 6G).
In experiments involving neocortical brain slices, the dose of pax-
illine that delivered consistent and reliable results was found to be
500 nM (data not shown), corresponding to the dose applied in vivo.
Our in vitro model system conﬁrmed the in vivo results, in that paxil-
line signiﬁcantly reduced the amplitude of the DC shift indicative of
rSDs, with respect to SD1 triggered in the same slice under aCSF
(−9.1 ± 5.3 vs. -15.7 ± 6.6mV), and with respect to rSDs triggered
in other slices under aCSF (−9.1 ± 5.3 vs. -17.2 ± 5.5mV) (Fig. 7).
In control experiments (i.e. perfused with aCSF throughout the ex-
perimental protocol), rSD amplitude fell in the same range as SD1
amplitude (17.2 ± 5.5 vs, 15.3 ± 5.3mV) (Fig. 7).
4. Discussion
In support of the working hypothesis that a surge of [K+]e directly
mediates vasoconstriction in response to SD in the cerebral cortex, we
Fig. 6. Pharmacological inhibition of large-conductance Ca2+-activated K+ (BK) channels by paxilline, and L-type voltage-sensitive Ca2+ channels (VGCC) by
nimodipine. A, Representative traces demonstrate the extracellular shift in K+ concentration ([K+]e; black traces), the direct current (DC) potential signature of
spreading depolarization (SD; gray traces), and the corresponding cerebral blood ﬂow (CBF) response (dashed traces) in a control experiment (left), a paxilline-
treated preparation (middle), and in case of incubation with nimodipine (right). Horizontal gray dotted lines indicate CBF minimum and CBF maximum in the control
experiment, to appreciate changes in the paxilline and nimodipine conditions with respect to control. The gray shaded time segment of the control recording covers
the duration of vasoconstriction, and is used as reference in the paxilline and nimodipine experiment. Note that after paxilline or nimodipine treatment, vasodilation
already evolves during this time segment of the SD event. B, Pie charts demonstrate the share of SD-coupled CBF responses displaying the ﬁrst, hypoperfusion
element. All SD events analyzed were taken as 100%. Dark gray color indicates CBF responses including early transient hypoperfusion; light gray color stands for CBF
responses devoid of the element of early hypoperfusion. C, Both paxilline and nimodipine decreased the area under the curve (AUC) relevant for early hypoperfusion
(one-way ANOVA: f= 3.802, p= .038*). For paxilline, early hypoperfusion evolved only in 1 out of 7 SDs. D, Both paxilline and nimodipine treatment reduced the
amplitude of the SD-related, negative DC shift (one-way ANOVA: f= 7.683, p= .003**). E, The level of extracellular K+ prior to SD initiation was similar over the
experimental groups (gray line at the base of the bars, and corresponding error bar; one-way ANOVA: f= 1.175, p= .322); paxilline and nimodipine treatment
reduced the relative amplitude of the K+ shift (one-way ANOVA: f= 6.702, p= .004**). F, The rate of the K+ shift was slower for both the paxilline and nimodipine
treated groups (one-way ANOVA: f= 22.791, p < .0001**). For all bar charts, data are given as mean ± stdev; n=25/33/34/33. Sample size (i.e. number of SD
events analyzed) is indicated in each bar. One-way analysis of variance (ANOVA) followed by a Fisher post hoc test was used for statistical analysis. The level of
signiﬁcance is given as p* < 0.05 and p** < 0.01 vs. control. G, The relative amplitude of the K+ shift with SD shows a positive correlation with the relative
amplitude of SD as indicated by the transient, negative shift of the DC potential. A one-tailed Pearson correlation paradigm was used for statistical analysis of the
data; n=33, r=0.683, p < .0001.
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implemented a two-photon microscopy approach to visualize the
spatio-temporal relationship between [K+]e variations and vascular
tone. This goal was achieved successfully by the in vivo application of
APG-2, a ﬂuorescent indicator of extracellular K+, in combination with
loading the cerebral vasculature with rhodamine dextran. Taken to-
gether, this is a pioneering report to show that K+ imaging with APG-2
can be implemented in a two-photon microscopic setting in anesthe-
tized mice, and is suitable for the detailed assessment of the coupling
between [K+]e variations and vascular tone.
We present here the original ﬁnding that the narrowing of cerebral
arterioles – both pial and cortical penetrating arterioles – is spatio-
temporally coupled with the sharp increase of [K+]e with SD.
Moreover, the reduced arteriolar diameter in response to SD must be
the result of active vasoconstriction, rather than a potential compres-
sion of vessels caused by SD-related swelling of neurons or dendritic
beading (Takano et al., 2007; Risher et al., 2010; Zhou et al., 2010),
because venules in our preparations maintained unchanging lumen
diameter with the passage of each SD.
Pathophysiological events such as ischemic injury ﬁrst give rise to a
moderate elevation of [K+]e, succeeded by spontaneous, recurrent SDs
commencing minutes later (Hansen, 1977; Hansen and Zeuthen, 1981).
Typically, the onset of ischemia is followed by a slow rise of [K+]e from
3 to 10mM (Hansen, 1977; Hansen and Zeuthen, 1981), a condition
thought to favor the generation of SD. Here we created progressively
increasing [K+]e in the absence of ischemia to examine how patho-
physiological tissue [K+]e levels alone relate to the characteristic fea-
tures of upcoming SD events. Our results demonstrate that increasingly
higher [K+]e in the cortical volume to be invaded by SD predicts pro-
portionally longer duration of the K+ shift as SD arrives (Fig. 5D1),
which conﬁrms previous results in brain slices (Dreier et al., 2001). In
other words, the recovery from the K+ shift with SD is hampered by
elevated baseline [K+]e. This may result from downregulation of α2
Na+/K+-ATPase (Dreier et al., 2001; Major et al., 2017), which in turn
impairs the functionality of astrocytes. Thus, in adult somatosensory
cortex of rats, the α2 isoform almost completely co-localizes with the
astrocytic glutamate transporters GLAST and GLT1 (EAAT1, EAAT2).
Analysis at the ultrastructural level showed that this complex occurs
preferentially in astrocytic processes around asymmetric glutamatergic
synaptic junctions, but not around GABAergic terminals (Cholet et al.,
2002). Insuﬃcient buildup of Na+ and K+ gradients in this subcellular
microdomain is assumed to decelerate glutamate reuptake, thereby
increasing glutamate in the synaptic cleft and delaying neuronal re-
covery from SD (Moskowitz et al., 2004). As elongated SD duration –
corresponding to K+ shift duration – has been recognized to facilitate
the conversion of tissue at risk to infarction during ischemia (Dreier,
2011; Hartings et al., 2017), the data suggest that baseline [K+]e, prior
to and in between recurrent SD events, is a predictive indicator of, and
plays a crucial role in ischemic lesion progression.
The early hypoperfusion element of the CBF response to SD has been
identiﬁed to escalate in the ischemic cortex, to put the survival of
metabolically compromised tissue at risk (Shin et al., 2006; Dreier,
2011; Hoﬀmann and Ayata, 2013; Bere et al., 2014). The inhibition of
nitric oxide synthase in combination with high [K+] was found to cause
the outright reduction of perfusion with the onset of SD, a phenomenon
that has become known as spreading ischemia (Dreier et al., 1998;
Dreier, 2011). Here we conﬁrm that the SD-related K+ shift alone
correlates positively with the depth and magnitude of the early hypo-
perfusion element of the CBF response to SD in the non-ischemic cortex
(Fig. 5D2-3) (Dreier et al., 2000). Thus, K+ accumulation itself appears
as a key mediator to determine the degree of early hypoperfusion with
SD, which may also result from decline in α2 Na+/K+-ATPase activity
because this enhances Ca2+ signaling in astrocytes, vascular myocytes,
and pericytes (Major et al., 2017). In support of the above suggestion,
and to identify potential vasoconstrictive mechanisms downstream to
tissue [K+]e elevation (Fig. 1), we manipulated the SD-related vaso-
constriction by BK channel or L-type VGCC inhibition in the cere-
brovascular domain. The selection of pharmacological agents relied on
the following grounds. Paxilline given at 1–2 μM concentration suc-
cessfully inhibited arteriolar dilation evoked by neuronal activation in
brain slices, and functional hyperemia in response to whisker-stimula-
tion (Girouard et al., 2010; Koide et al., 2012; Kim et al., 2015). These
studies concluded that endfeet BK channels were essential in the reg-
ulation of vascular tone during neurovascular coupling. Moreover, the
intravenous administration of nimodipine was found to alleviate
spreading ischemia with SD under elevated baseline [K+]e combined
with NO deprivation (Dreier et al., 1998; Dreier et al., 2002). Accord-
ingly, nimodipine also potently antagonized the vasoconstriction im-
posed by high perivascular [K+]e in the isolated middle cerebral artery
of rats (Windmüller et al., 2005). With these encouraging evidence in
mind, we set out to apply paxilline or nimodipine on the brain surface
Fig. 7. Pharmacological inhibition of large-conductance Ca2+-activated K+ (BK) channels by paxilline in acute, live, neocortical brain slices. A, Schematic re-
presentation of the preparation used for the recording of local ﬁeld potential (LFP) that was ﬁltered in direct current (DC) mode. B, Representative traces demonstrate
that the amplitude of the negative DC potential shift indicative of spreading depolarization (SD) remains constant under artiﬁcial cerebrospinal ﬂuid (aCSF) in-
cubation (gray), but becomes signiﬁcantly smaller at the presence of 500 nM paxilline (black). SD pairs were taken from representative brain slice preparations.
Recurrent SDs (rSDs) shown are the third or fourth SD in a train, elicited 50min after triggering the respective SD1. C, The amplitude of the negative DC potential
shift indicative of SD. Note that in both conditions (i.e. control and 500 nM paxilline), SD1 was triggered under aCSF incubation, and paxilline in the treated group
was washed on the slice 8min prior to initiating rSDs. Data are given as mean ± stdev. Sample size (i.e. number of SD events analyzed) is indicated in each bar. One-
way analysis of variance (ANOVA) followed by a Fisher post hoc test was used for statistical analysis. The level of signiﬁcance is given as p* < 0.05 vs. respective
SD1, and p## < 0.01 vs. control rSD. Abbreviations: CPu: caudate putamen, cx, cerebral cortex.
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of anesthetized mice to evaluate their impact on the SD-coupled initial
hypoperfusion under elevated baseline [K+]e.
Paxilline used here at 500 nM concentration (i.e. half of the lowest
concentration reported earlier) exhibited a profound inhibitory eﬀect,
by virtually abolishing the early hypoperfusion element of the CBF
response to SD (Fig. 6B). Nimodipine, though less potent, also reduced
the size of early hypoperfusion remarkably (Fig. 6C). Hence, both
pharmacological interventions conﬁrmed the working hypothesis
(Fig. 1), and proved the involvement of BK channels and L-type VGCC
in the mediation of vasoconstriction in response to SD under elevated
baseline [K+]e. It is noteworthy that paxilline was previously shown to
inhibit vasodilation to moderate [K+] elevation (< 10mM) (Girouard
et al., 2010), while the data gathered here bring new evidence by de-
monstrating that paxilline blocks vasoconstriction produced by [K+]e
above 20mM. As previously discussed (Dreier et al., 1998), the an-
tagonistic eﬀect of nimodipine against the SD-induced vasoconstriction
is in agreement with the clinical observation that nimodipine decreased
the risk of poor outcome in patients with aSAH by 42% (Tettenborn and
Dycka, 1990). Notably, this eﬀect resulted from the reduction in oc-
currence and severity of delayed cerebral ischemia but not from the
reduction of angiographically visible vasospasm (Allen et al., 1983;
Espinosa et al., 1984; Petruk et al., 1988).
Whether the drug eﬀects were achieved by the selective targeting of
the cerebrovascular domain remains uncertain, because both paxilline
and nimodipine reduced the amplitude of SD (Fig. 6D; Fig. 7), and
curtailed the evolution of the K+ shift with SD (Fig. 6E–F). The re-
duction of SD amplitude is suggested to be directly linked to the
treatment-related, decreasing amplitude of the K+ shift with SD
(Fig. 6G) (Hansen and Zeuthen, 1981). The observations with paxilline
raise the innovative concept that K+ eﬄux during the depolarization
phase of SD should manifest through BK channels to a signiﬁcant de-
gree. Neuronal whole cell patch clamp studies previously provided
evidence that the ion dislocations at the rise of SD represent non-
selective Na+(Ca2+)/K+ conductances, which implies massive K+ ef-
ﬂux involving various K+ channels (Czéh et al., 1992, 1993). Even
though neither tetraethylammonium, a drug that targets inward recti-
fying and delayed outward rectifying K+ channels (Cook, 1990), nor 4-
aminopyridine, a blocker of inward rectiﬁer and A-type K+ channels
(Aitken et al., 1991; Somjen, 2001), were suﬃcient to fully block SD,
they unmasked some contribution of these channels. For example, tet-
raethylammonium reduced the eﬄux of K+. Further, K+ may leave the
cells during SD via ATP-sensitive K+ channels under metabolic stress
(Somjen, 2001). While these non-selective Na+(Ca2+)/K+ con-
ductances probably lead the depolarization, the notable, selective,
possibly secondary contribution of BK channels to the SD-related rise of
[K+]e is ﬁrst shown here. Nevertheless, the action of paxilline on SD in
our experiments was not expected, because concentrations as high as
1 μM had been reported to be selective for astrocytic endfeet, leaving
neuronal BK channels unaﬀected (Girouard et al., 2010). If the 500 nM
concentration we used was truly selective for astrocytes, astrocytic BK
channels located elsewhere than at the perivascular endfeet must have
signiﬁcantly contributed to the [K+]e surge with SD. However, it
cannot be excluded that paxilline may have also blocked neuronal BK
channels abundant on soma and dendrites, which have been known to
adjust neuronal excitability (Latorre et al., 1989; Faber and Sah, 2003),
and have been implicated in the reduced susceptibility of the nervous
tissue to SD under hypoxia (Hepp et al., 2005). Moreover, blockade of
neuronal BK channels with systemic paxilline administration (2.2 μg/kg
body weigh) was shown to eﬀectively prevent experimentally induced
seizure activity (Sheehan et al., 2009), a pathophysiological phenom-
enon that shares several mechanisms with SD and can occur together
with SD in the acutely injured brain (Fabricius et al., 2008; Dreier et al.,
2012). Theoretically, paxilline could have blocked the initial hypo-
perfusion to SD in our experiments either indirectly, by reducing [K+]e,
or directly, acting on endfeet BK channels. However, because paxilline
did not reduce [K+]e below the vasoconstrictive threshold (peak
amplitude after treatment was 29.7 ± 5.4mM; Fig. 6E), but abolished
SD-induced hypoperfusion almost entirely (Fig. 6B), it is more likely
that the inhibition of vasoconstriction was mostly achieved through
inhibition of BK channels at the perivascular endfeet.
Nimodipine also altered SD evolution markedly. In addition to
VSMC, neurons also express L-type VGCCs, which have been implicated
in the modiﬁcation of neuronal excitability (Moyer Jr et al., 1992), and
are a well-known target of neuroprotection to counteract neuronal
Ca2+ overload in ischemic brain injury (Scriabine et al., 1989; Rami
and Krieglstein, 1994). Nimodipine previously inhibited moderately the
frequency, latency and amplitude of recurrent SDs triggered with KCl in
the rat cerebral cortex at a concentration identical to that used here
(Richter et al., 2002). We found, however, that nimodipine con-
siderably reduced the rate and, to a smaller degree, the peak amplitude
of the K+ shift with SD (Fig. 6E–F). In support of our data, nimodipine
was found to block 50% of both calcium-dependent and voltage-de-
pendent K+ currents, recorded in a whole cell patch clamp conﬁgura-
tion during action potential ﬁring of cultured rat hippocampal neurons
(Caro et al., 2011). In addition, L-type VGCCs were demonstrated to
gate BK channels in cortical pyramidal neurons (Contet et al., 2016). It
seems, therefore, likely, that in addition to blocking L-type VGCCs on
vascular VSMC, nimodipine alleviated the early hypoperfusion element
of the CBF response to SD also by slowing outward K+ currents, thereby
weakening K+-mediated vasoconstriction.
Overall, the data gathered here are highly relevant and translate to
neurological disease states (i.e. subarachnoid hemorrhage, ischemic
stroke and traumatic brain injury), in which SDs reoccur from minutes
to weeks after the primary insult, and contribute to lesion progression
by the coupled hypoemic ﬂow transients (Dreier, 2011; Dreier et al.,
2017; Hartings et al., 2017). Importantly, high concentration potassium
in the nervous tissue emerges as a major cause of SD-related early va-
soconstriction. Finally, BK channels – whether at the astrocytic endfeet
or on neurons – play a signiﬁcant role in SD evolution, and the reg-
ulation of the associated, early-onset vasoconstriction.
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